ROR1 and neoplasm: Potential limitations of our study include the analysis of pretreatment tumor specimens only, analysis of gene expression only, and use of Agilent 44 K platform which cannot distinguish between RNA isoforms of ROR1 or ROR2 that can or cannot be expressed as cell surface proteins [14].